Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Burlingame › NPI 1043670334
Hospital

Sutter Bay Hospitals

Sutter Bay Hospitals was paid $17.15M by Medicaid between Jan 2018 and Dec 2024, across 248 billing codes. Its largest line is 0450, Emergency room services — 19% of everything it billed.

33Billing provider infoSUTTER BAY HOSPITALS
BURLINGAME, CA 94010
33aNPI1043670334assigned 02/29/2016
33bProvider typeGeneral Acute Care Hospital
28Total paid$17.15M
24GClaims712,649
24DCodes billed248
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#134 of 410
Median peer was paid$6.90M
This provider vs. median2.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official GATES, JOHN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018104,908$2.26M
2019109,811$2.31M
202085,552$1.94M
2021101,880$2.27M
2022105,926$2.53M
2023107,941$2.92M
2024incomplete96,631$2.92M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 19% 52,613 46,606 $3.18M
97139 4.2% 40,132 7,664 $721K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.5% 9,247 8,472 $596K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.3% 3,123 3,043 $563K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.2% 3,859 3,520 $554K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 3.1% 7,244 6,424 $538K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 3.1% 10,760 3,766 $530K
70450 Computed tomography, head or brain; without contrast material 3.0% 3,681 3,558 $512K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.3% 47,335 42,411 $394K
80053 Comprehensive metabolic panel 2.3% 36,433 33,887 $389K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.2% 14,831 13,643 $373K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2.2% 7,425 7,136 $369K
236 more codes
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2.0% 5,873 $350K
77067 Screening mammography, bilateral, including computer-aided detection 2.0% 5,242 $340K
99283 Emergency room visit (moderate) 1.4% 4,849 $241K
97799 1.4% 12,847 $239K
84443 Thyroid stimulating hormone (TSH) 1.3% 14,135 $225K
96375 Therapeutic injection; each additional sequential IV push 1.3% 5,791 $222K
97750 1.1% 5,242 $184K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 1,089 $171K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 5,653 $163K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 2,361 $156K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 3,051 $154K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,274 $149K
80061 Lipid panel <1% 17,450 $148K
71046 Radiologic examination, chest; 2 views <1% 6,530 $143K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 810 $142K
96361 Intravenous infusion, hydration; each additional hour <1% 4,343 $141K
83036 Hemoglobin; glycosylated (A1C) <1% 15,732 $139K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 400 $138K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,045 $135K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 2,410 $134K
86481 <1% 2,090 $131K
90791 Psychiatric diagnostic evaluation <1% 1,112 $128K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,348 $128K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,023 $127K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,031 $127K
71045 Radiologic examination, chest; single view <1% 9,030 $124K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 338 $118K
80048 Basic metabolic panel (calcium, ionized) <1% 14,516 $112K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 12,979 $112K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,603 $109K
76830 Ultrasound, transvaginal <1% 1,534 $104K
84484 <1% 8,977 $102K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,569 $102K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 5,733 $102K
76641 <1% 1,551 $97K
77063 Screening digital breast tomosynthesis, bilateral <1% 5,238 $87K
70551 Magnetic resonance imaging, brain; without contrast material <1% 215 $80K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 9,141 $74K
99199 Unlisted special service, procedure or report <1% 947 $73K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,133 $69K
83690 <1% 7,187 $68K
97113 <1% 2,557 $68K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,230 $67K
71275 Computed tomographic angiography, chest, with contrast material <1% 424 $67K
81001 <1% 18,189 $63K
77066 Tomosynthesis, mammo <1% 647 $62K
77080 <1% 4,253 $57K
87086 Culture, bacterial; quantitative colony count, urine <1% 7,340 $54K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 5,505 $51K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 128 $49K
93970 <1% 292 $49K
J7030 Infusion, normal saline solution , 1000 cc <1% 6,344 $48K
87040 <1% 3,884 $46K
99070 <1% 18,318 $46K
84439 <1% 5,255 $44K
86803 <1% 1,772 $43K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 251 $41K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,891 $39K
83880 <1% 2,864 $38K
J3490 Unclassified drugs <1% 7,027 $38K
73030 <1% 1,551 $38K
81025 <1% 4,368 $36K
71250 <1% 280 $35K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 239 $35K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 501 $35K
87486 <1% 603 $35K
87581 <1% 601 $35K
73610 <1% 1,244 $34K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 314 $33K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 1,609 $32K
83605 <1% 2,862 $32K
72100 <1% 1,152 $32K
87186 <1% 3,766 $31K
72125 Computed tomography, cervical spine; without contrast material <1% 159 $31K
82077 <1% 1,540 $31K
86480 <1% 511 $30K
83970 <1% 1,943 $29K
73630 <1% 1,135 $28K
73562 <1% 1,110 $26K
85027 <1% 5,186 $25K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,044 $24K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,974 $23K
85379 <1% 1,755 $23K
0750 <1% 116 $21K
81003 <1% 8,370 $21K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 3,294 $21K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,113 $20K
97165 <1% 515 $20K
77065 Tomosynthesis, mammo <1% 258 $19K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 543 $19K
71271 <1% 226 $19K
85610 <1% 5,209 $18K
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,070 $18K
82947 <1% 5,076 $17K
82728 <1% 2,477 $17K
87634 <1% 293 $17K
76770 <1% 252 $17K
75574 <1% 78 $16K
83735 <1% 2,761 $15K
A9585 Injection, gadobutrol, 0.1 ml <1% 689 $15K
73130 <1% 606 $15K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,699 $15K
84145 <1% 1,027 $15K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 51 $14K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,133 $14K
87077 <1% 3,578 $14K
76536 <1% 290 $14K
82043 <1% 4,454 $12K
85730 <1% 1,690 $12K
87340 <1% 571 $12K
86140 <1% 2,097 $12K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,589 $12K
82570 <1% 5,304 $11K
86850 <1% 1,142 $10K
83540 <1% 3,016 $10K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,610 $10K
J2060 Injection, lorazepam, 2 mg <1% 1,599 $10K
87430 <1% 626 $10K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,145 $9K
80076 <1% 1,334 $9K
87081 <1% 941 $9K
84460 <1% 2,532 $9K
83550 <1% 2,766 $9K
84153 <1% 1,106 $9K
73502 <1% 442 $9K
84450 <1% 2,367 $9K
76642 <1% 173 $9K
87070 <1% 1,106 $8K
T1999 Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" <1% 813 $8K
76801 <1% 124 $7K
82274 <1% 1,782 $7K
86901 <1% 1,329 $7K
73564 <1% 222 $7K
0270 <1% 259 $7K
85652 <1% 2,968 $6K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 782 $6K
0762 <1% 121 $6K
80069 <1% 1,940 $6K
73110 <1% 220 $6K
84550 <1% 2,561 $6K
93971 <1% 64 $5K
82550 <1% 1,254 $5K
70496 <1% 25 $5K
86900 <1% 1,393 $5K
93017 <1% 99 $5K
73560 <1% 257 $4K
86704 <1% 165 $4K
73221 <1% 12 $4K
86765 <1% 175 $4K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 845 $4K
86735 <1% 157 $4K
86762 <1% 175 $4K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 137 $4K
84100 <1% 1,164 $4K
86706 <1% 151 $3K
73140 <1% 177 $3K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 24 $3K
97161 <1% 133 $3K
97162 <1% 163 $3K
93798 <1% 147 $3K
83655 <1% 500 $3K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 46 $3K
Z7502 <1% 78 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 444 $3K
82607 <1% 2,404 $3K
84075 <1% 946 $3K
92508 Group treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 97 $3K
92522 <1% 30 $3K
86592 <1% 448 $3K
92523 <1% 29 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 143 $2K
87045 <1% 136 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 284 $2K
82951 <1% 83 $2K
74018 <1% 97 $2K
86787 <1% 62 $2K
82565 <1% 696 $2K
87400 <1% 319 $1K
77336 <1% 50 $1K
84156 <1% 1,397 $1K
87517 <1% 19 $1K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 12 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 39 $1K
87075 <1% 203 $1K
97116 <1% 296 $1K
87205 <1% 470 $1K
92610 <1% 51 $1K
93270 <1% 24 $1K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 153 $1K
36415 Collection of venous blood by venipuncture <1% 28,607 $1K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 20 $1K
73080 <1% 40 $1K
72040 <1% 40 $997.01
87147 <1% 167 $906.06
80143 <1% 54 $865.00
87480 <1% 26 $744.22
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 121 $742.91
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 18 $718.34
87510 <1% 26 $715.81
87046 <1% 200 $633.76
J1815 Injection, insulin, per 5 units <1% 20 $615.25
80055 <1% 12 $589.82
87088 <1% 79 $555.03
84702 <1% 30 $528.27
82803 <1% 13 $514.60
71020 <1% 12 $490.29
87420 <1% 31 $471.83
86038 <1% 25 $444.89
85007 <1% 409 $408.66
86769 <1% 13 $404.87
80179 <1% 26 $404.79
J7050 Infusion, normal saline solution, 250 cc <1% 104 $399.11
87660 <1% 26 $397.81
90715 <1% 12 $352.99
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 61 $337.24
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 93 $284.77
82746 <1% 36 $277.90
86695 <1% 13 $270.75
J0780 Injection, prochlorperazine, up to 10 mg <1% 15 $259.37
94726 <1% 12 $248.97
86696 <1% 13 $222.77
94729 <1% 12 $203.92
J1630 Injection, haloperidol, up to 5 mg <1% 59 $184.36
82247 <1% 27 $179.97
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg <1% 23 $150.00
0250 <1% 14 $129.76
82248 <1% 15 $111.41
82040 <1% 27 $75.20
84480 <1% 13 $66.92
83615 <1% 17 $57.95
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml <1% 56 $53.20
85018 <1% 13 $37.30
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 197 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 276 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 31 $0.00
G0378 Hospital observation service, per hour 0% 44 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGATES, JOHN (CFO)
Same official

Other billing entities under GATES, JOHN

Full network →
ProviderLocationPaid
Sutter Bay HospitalsCastro Valley, CA$52.65M
Sutter Bay HospitalsOakland, CA$46.80M
Sutter Bay HospitalsBerkeley, CA$43.78M
Sutter Bay HospitalsLakeport, CA$39.50M
Sutter Bay HospitalsSanta Rosa, CA$35.23M
Sutter Bay HospitalsAntioch, CA$29.48M
Sutter Bay HospitalsSan Francisco, CA$19.99M
Sutter Bay HospitalsSan Francisco, CA$14.94M
Sutter Bay HospitalsNovato, CA$11.12M
Sutter Bay HospitalsSan Francisco, CA$6.79M
Sutter Bay HospitalsLakeport, CA$3.99M
Sutter East Bay HospitalsAntioch, CA$3.45M
Sutter Bay HospitalsBurlingame, CA$1.98M
Sutter Bay HospitalsLakeport, CA$1.72M
Sutter East Bay HospitalsOakland, CA$1.10M
Sutter Bay HospitalsSan Francisco, CA$1.08M
Sutter East Bay HospitalsBerkeley, CA$946K
Sutter West Bay HospitalsSan Francisco, CA$186K
Magnetic Imaging Affiliates, LLCOakland, CA$112K
Sutter Bay HospitalsBerkeley, CA$45K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.